Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.67 |
| ▸ | GABRD | O14764 | 2/20 | 0.67 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.67 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.67 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.67 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.67 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.67 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.67 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.67 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.67 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.67 |
| ▸ | GABRE | P78334 | 2/20 | 0.67 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.67 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.67 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.67 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538579 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1881592 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31158246 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1876354 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1879457 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882607 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL244824 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1885384 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882596 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1880221 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672935-A1 | PROCESS FOR PURIFYING LONG CHAIN AMINO ACIDS | Vitaworks IP, LLC (US) | 2020-07-01 | — | — | EP | claimed |
| CN-111032623-A | Process for purifying long-chain amino acid | 维生源知识产权有限责任公司 | 2020-04-17 | — | — | CN | claimed |
| WO-2019118072-A1 | PROCESS FOR PURIFYING LONG CHAIN AMINO ACIDS | VITAWORKS IP, LLC (US) | 2019-06-20 | — | — | WO | claimed |
| US-10239823-B2 | Process for purifying long chain amino acids | VITAWORKS IP, LLC | 2019-03-26 | — | — | US | claimed |
| WO-2019040177-A1 | PROCESS FOR PURIFYING LONG CHAIN AMINO ACIDS | VITAWORKS IP, LLC (US) | 2019-02-28 | — | — | WO | claimed |
| CN-1380064-A | Method for producing antibiotic preparation and its application | HERAEUS GUSA GMBH & CO KG (DE) | 2002-11-20 | — | — | CN | claimed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-6706777-B1 | CAN BE CURED IN THE ABSENCE OF A PHOTOINITIATOR WITH A IRRADIATION SOURCE OF PRACTICAL INTENSITY AND ENERGY VALUE | SUN CHEMICAL CORPORATION | 2004-03-16 | — | — | US | disclosed |
| EP-0878482-B1 | An active energy ray curable composition comprised of a maleimide derivative and a method for curing the said curable composition | DAINIPPON INK & CHEMICALS (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-20020183265-A1 | Manufacture and use of an antibiotic/antibiotics preparation | HERAUES KULZER GMBH & CO.KG (DE) | 2002-12-05 | — | — | US | disclosed |
| US-20020182251-A1 | Antibiotic(s) preparation with retarding active ingredient release | HERAUES KULZER GMBH & CO.KG (DE) | 2002-12-05 | — | — | US | disclosed |
| CN-1380064-A | Method for producing antibiotic preparation and its application | HERAEUS GUSA GMBH & CO KG (DE) | 2002-11-20 | — | — | CN | disclosed |
| US-6410611-B1 | COATINGS, SURFACE FINISHES, BINDERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-06-25 | — | — | US | disclosed |
| EP-0878482-A1 | An active energy ray curable composition comprised of a maleimide derivative and a method for curing the said curable composition | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10239823-B2 | Process for purifying long chain amino acids | BCAT1, SLC43A1, BCAT2 | GABRP 223/4885GABRD 368/4885GABRA1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.